The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
about
Prostate MRI based on PI-RADS version 2: how we review and reportThe evolving Gleason grading systemBeyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifierOutcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.Heat-shock factor 2 is a suppressor of prostate cancer invasion.The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.Grading of prostatic adenocarcinoma: current state and prognostic implicationsOne is the new six: The International Society of Urological Pathology (ISUP) patient-focused approach to Gleason gradingMicroRNA‑328 directly targets p21‑activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivityEvaluation and prognostic significance of ACAT1 as a marker of prostate cancer progressionLoss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapseCan contemporary patients with biopsy Gleason score 3+4 be eligible for active surveillance?A novel miRNA-based predictive model for biochemical failure following post-prostatectomy salvage radiation therapyStromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancerOverexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate CancerProstate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal TherapyPlakophilin-associated RNA-binding proteins in prostate cancer and their implications in tumor progression and metastasis.Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data.The accuracy of pathological data for the prediction of insignificant prostate cancer.Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors.Clinical performance of the Prostate Health Index (PHI) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre European prospective study.Information-based ranking of 10 compartment models of diffusion-weighted signal attenuation in fixed prostate tissue.Hierarchical non-negative matrix factorization applied to three-dimensional 3 T MRSI data for automatic tissue characterization of the prostate.A measure of association for ordered categorical data in population-based studies.Microvascularity in transition zone prostate tumors resembles normal prostatic tissue.DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.Towards improved cancer diagnosis and prognosis using analysis of gene expression data and computer aided imaging.TRPV6 alleles do not influence prostate cancer progressionAnalytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsiesCumulative effect of five genetic variants on prostate cancer risk in multiple study populations.Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.Two independent prostate cancer risk-associated Loci at 11q13A novel prostate cancer susceptibility locus at 19q13Association of prostate cancer risk variants with clinicopathologic characteristics of the diseaseComparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsyProspective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1.Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.Determination of adequate pelvic lymph node dissection range for Japanese males undergoing radical prostatectomy
P2860
Q26749289-F9AC3BAB-5588-48D1-8BA9-3132213A96C7Q26752936-512C8444-222A-4268-99C0-635B2C91DACDQ27301431-DD1E5401-4218-4905-957F-8E4326689F71Q27308897-B8A88E1C-1A08-4B55-9266-1E51FD7CCC7BQ27309985-7AD5FABC-A5D4-427E-A57F-0C8265D729F3Q27311513-E652EB71-FAFF-45F1-901D-1D29DC75EA25Q27852034-FC6C2D70-7C7A-41C7-A83C-96E993C4D63FQ28066111-D42B3B0B-7382-4E7B-A094-B50141646046Q28070143-E8258A69-4232-4141-9549-F69E84EC4B38Q28268506-CF0E62F0-04BE-431D-9F24-67238C1CA367Q28303423-CB06AAA1-9377-4F37-8BDB-C6898E5AEB8FQ28540624-F9C2CD96-CB64-469B-B5E3-95FDFF99FC96Q28543448-2650390C-DFD6-4CDE-A8D4-9B43A8877966Q28543958-55D98A53-DA8E-4903-A98E-D2E2CAE17C58Q28544996-B9D38422-8BF0-4123-B366-B0B471E9185DQ28545072-636EF71E-8F67-4C4F-AB6B-88FF4A689EAAQ28546607-31626103-FE96-4930-AF3B-9BC925E67A84Q28550782-2D0B9729-5872-4B1A-844D-4FA3823C6CABQ30009601-E8C84405-1503-431B-B7A5-41583839574FQ30568800-3D272B1B-689A-4DA1-948F-C0173FD762DAQ30585256-41423F1C-2954-4E4D-BDFD-CCE926AF5819Q30652492-2C836062-9CC5-4256-90B8-D2223B75F7F7Q30843223-B934D9E6-2844-4CDB-8F05-661B048BE72AQ31061248-731C40AD-DE59-4F73-B1FB-B4721FC0EB6CQ31072477-BD99A73E-B98A-4E81-9BB9-2DEBAB97DEB0Q31096460-9C5B2DAC-8382-4C5E-A998-0265C954BA37Q31097312-A1A80593-EDEF-4A75-BA44-38CBC0D7EB41Q31154890-E11D28FB-9832-44E5-8A46-59BE335D6ED4Q33459037-69D08750-9FAD-4650-BF8C-8C34F3C843BDQ33512614-55E1E281-5AFA-4A4E-806B-BE8F4F84D4A4Q33557377-7E78301D-21B5-4907-B0A9-218FC0E3A7B6Q33566598-F589FD94-0DD8-4DA0-A661-162B275B7176Q33566981-823B4F53-5C97-4F86-8AF5-1FD6312B6226Q33573689-D77A0197-5FC8-47A1-8B83-E82880AD25D0Q33578264-B5C0C44F-B336-4BC3-9498-4D3F477F6985Q33606941-48BFFB73-1EFE-4191-9296-89098707BB3BQ33611513-D484C1B1-239E-4C2D-823B-6CD9D316E640Q33668692-BE123DE2-8F18-41D5-B190-7916C22E353EQ33671496-159B5E70-C1D5-48F5-9B37-CF19D3292488Q33684820-E53A9736-AE6E-43B8-98BA-D091F60ABC48
P2860
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The 2005 International Society ...... rading of Prostatic Carcinoma.
@ast
The 2005 International Society ...... rading of Prostatic Carcinoma.
@en
type
label
The 2005 International Society ...... rading of Prostatic Carcinoma.
@ast
The 2005 International Society ...... rading of Prostatic Carcinoma.
@en
prefLabel
The 2005 International Society ...... rading of Prostatic Carcinoma.
@ast
The 2005 International Society ...... rading of Prostatic Carcinoma.
@en
P2093
P1476
The 2005 International Society ...... rading of Prostatic Carcinoma.
@en
P2093
ISUP Grading Committee
Jonathan I Epstein
Lars L Egevad
Mahul B Amin
William C Allsbrook
P304
P356
10.1097/01.PAS.0000173646.99337.B1
P407
P577
2005-09-01T00:00:00Z